Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus?
- PMID: 21836104
- PMCID: PMC3177752
- DOI: 10.2337/dc11-0499
Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus?
Abstract
Objective: To identify patients with gestational diabetes mellitus (GDM) who will need antenatal insulin treatment (AIT) by using a risk-prediction tool based on maternal clinical and biochemical characteristics at diagnosis.
Research design and methods: Data from 3,009 women attending the Royal Prince Alfred Hospital GDM Clinic, Australia, between 1995 and 2010 were studied. A risk engine was developed from significant factors identified for AIT using a logistic regression model.
Results: A total of 51% of GDM patients required AIT. Ethnicity, gestation at diagnosis, HbA(1c), fasting and 60-min glucose at oral glucose tolerance test, BMI, and diabetes family history were significant independent determinants of AIT. Notably, only 9% of the attributable risk for AIT can be explained by the clinical factors studied. A modeled risk-scoring system was therefore a poor predictor of AIT.
Conclusions: Baseline maternal characteristics including HbA(1c) alone cannot predict the need for AIT in GDM. Lifestyle, compliance, or as yet unmeasured influences play a greater role in determining AIT.
References
-
- Flack JR, Ross GP, Ho S, McElduff A. Recommended changes to diagnostic criteria for gestational diabetes: impact on workload. Aust N Z J Obstet Gynaecol 2010;50:439–443 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous